Eli Lilly and Company today announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
from Dementia Big http://ift.tt/20u4D3J
via Stopping Dementia
from WordPress http://ift.tt/1VtI5wD
via alcoholic dementia
http://ift.tt/1Tp2GU0
No comments:
Post a Comment